test

Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (RTOG 0920) (CIRB)

Conditions

Head and Neck Cancer

Trial Phase

Trial Purpose and Description

Trial Purpose


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Eligibility Criteria

Sponsor:
Radiation Therapy Oncology Group
Dates:
July 2011
Last Updated:
Study HIC#:
1106008671